INDEX 



957 



Myxedema, thyroid treatment' of, 

 changes in patient wrought by, 87. 



differentiated from acromegaly, 851. 

 dosage for, 90, 91. 



effect of, on atrophied thyroid 

 gland, 89. 

 history of, 61. 

 -Murray's, 81, 84. 



Myxomatous changes in hypophysis 

 cerebri, 777. 



Nails, disturbances of, of autonomic 

 origin, 331. 



in hypothyroidism, 408. 



in tetany, 614. 



Nasal disease, causing exophthalmic 



goiter, 308. 

 Nausea and vomiting of pregnancy, 



ovarian therapy in, 157. 

 Necrosis, of hypophysis cerebri, 775. 

 Neoplasms, of hypophysis cerebri, 



796. 



primary, of the parathyroids, 570. 

 Nephritis, edema, differentiated from 



hypothyroidism, 424. 



thyroid treatment of, 104. 



Nerve involvement, in dystrophia adi- 

 posogenitalis, 866. 



Nerve stimulation, in administration 

 of gland extracts, 38. 



Nervous control of pancreas, 175. 



Nervous manifestations, following cas- 

 tration, 177. 



of dystrophia adiposogenitalis, 894. 

 Nervous symptoms, in thyroid disease, 



cerebral nerve paralysis, 354. 



epilepsy, 354. 



hysteria, 353. 



paralysis agitans, 354. 



paraplegia and hemiplegia, 353. 



tabes dorsalis, 354. 



tetany, 354. 



Thomsen's disease, 354. 



tuberculosis, 355. 



Nervous system, autonomic. See Auto- 

 nomic nervous system. 



central, action of internal secretions 

 on, 76. 



difference between autonomic and 

 central or cerebrospinal, 73. 



exophthalmic goiter, as due to 

 changes in the sympathetic, 312. 



as due to changes in the vegeta- 

 tive, 313. 

 j n cretinic degeneration, 461. 



in cretinic degeneration, 466. 



in hypothyroidism, 389. 



Nervous system, nonvegetative, action 

 of epinephrin on, pharmacodynamic, 

 128. 



relation of, to parathyroid tetany, 531. 



relation of tonus of, to internal 

 secretions of ductless glands, 74, 75. 



Neurasthenia, differentiated from ex- 

 ophthalmic goiter, 359. 



from hypothyroidism, 425. 

 Neuritis, peripheral, differentiated from 



tetany, 681. 

 Neurogenic theory of exophthalmic 



goiter, 311. 



Neurohypophysis, pigmentation in, 777. 

 Neurological practice, ovarian therapy 



in, 158. 

 Neuromuscular symptoms, associated 



with thyroid disease, cerebral, 346. 



motor symptoms, 348. 



sensory, 347. 



special senses, 348. 



Neuropathies, of postulated parathyro- 



pathic origin, chorea minor, 700. 



hyperparathyroid psychosis, 701. 



myasthenia gravis, 700. 



myoclonia, 700. 



Parkinson's disease, 698. 



Thompson's disease, 699. 



Neurosis, general, exophthalmic goiter 



as, 312. 

 New growths, of hypophysis cerebri, 



with associated obesity, 906. 

 Nucleins and purins, in tetany, inos- 



mic acid, 635. 



phosphoric acid, 635. 



xanthin and its derivatives, 634. 



Nucleo-proteins, 29. 



Nutritional factors, in hypothyroidism, 



385. 



Obesities, differentiated from hypothy- 

 roidism, 425. 



Obesity, in dystrophia adiposogenitalis, 

 896. 



of hypogenital origin, ovarian thera- 

 py in, 157. 



in pineal gland lesions, 909. 



pituitary, pituitary therapy for, 112. 

 pituitary (anterior) therapy in, 



120. 



thyrogenic, as sign of hypothyroid 

 state, 406. 



thyroid treatment of, 96. 

 Occupation, as factor in cretinic de- 

 generation, 449. 



in exophthalmic goiter, 306. 



in tetany, idiopathic, 646. 



